Daniele Presti

557 total citations
17 papers, 223 citations indexed

About

Daniele Presti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Daniele Presti has authored 17 papers receiving a total of 223 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Daniele Presti's work include Advanced Breast Cancer Therapies (4 papers), Cancer Risks and Factors (4 papers) and Breast Cancer Treatment Studies (3 papers). Daniele Presti is often cited by papers focused on Advanced Breast Cancer Therapies (4 papers), Cancer Risks and Factors (4 papers) and Breast Cancer Treatment Studies (3 papers). Daniele Presti collaborates with scholars based in Italy, France and Canada. Daniele Presti's co-authors include Erica Quaquarini, Antonio Di Meglio, Davide Soldato, Joana Ribeiro, Benjamin Besse, Filippo Gustavo Dall’Olio, Raffaella Palumbo, Cristina Teragni, Federico Sottotetti and Antônio Bernardo and has published in prestigious journals such as Cancer, Cancer Research and Annals of Oncology.

In The Last Decade

Daniele Presti

16 papers receiving 222 citations

Peers

Countries citing papers authored by Daniele Presti

Since Specialization

Citations

This map shows the geographic impact of Daniele Presti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniele Presti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniele Presti more than expected).

Fields of papers citing papers by Daniele Presti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniele Presti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniele Presti. The network helps show where Daniele Presti may publish in the future.

Co-authorship network of co-authors of Daniele Presti

This figure shows the co-authorship network connecting the top 25 collaborators of Daniele Presti. A scholar is included among the top collaborators of Daniele Presti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniele Presti. Daniele Presti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	The pan-immune-inflammation value is associated with clinical outcomes in patients with advanced TNBC treated with first-line, platinum-based chemotherapy: an institutional retrospective analysis 2023 ·Therapeutic Advances in Medical Oncology ·Leonardo Provenzano, Riccardo Lobefaro, Francesca Ligorio, Emma Zattarin, (unknown), (unknown), Daniele Presti, (unknown), (unknown), Antonia Martinetti, (unknown), (unknown), (unknown), Barbara Formisano, Giulia Bianchi, Giuseppe Capri, Filippo de Braud, Claudio Vernieri, Giovanni Fucà	17
2	Coffee and tea consumption, patient‐reported, and clinical outcomes in a longitudinal study of patients with breast cancer 2022 ·Cancer ·Davide Soldato, Julie Havas, Tracy E. Crane, Daniele Presti, (unknown), (unknown), Barbara Pistilli, Élise Martin, Lucia Del Mastro, Anne‐Laure Martin, Alexandra Jacquet, Charles Coutant, Paul Cottu, (unknown), Florence Lerebours, Olivier Trédan, Laurence Vanlemmens, Fabrice André, Inês Vaz-Luís, Antonio Di Meglio	3
3	Efficacy and Safety of First-line Carboplatin-paclitaxel and Carboplatin-gemcitabine in Patients With Advanced Triple-negative Breast Cancer: A Monocentric, Retrospective Comparison 2022 ·Clinical Breast Cancer ·Riccardo Lobefaro, Luigi Mariani, (unknown), Francesca Ligorio, Giovanni Fucà, (unknown), Emma Zattarin, Rita Leporati, Daniele Presti, (unknown), (unknown), Andrea Vingiani, Siranoush Manoukian, Gianfranco Scaperrotta, Giulia Bianchi, Giuseppe Capri, Giancarlo Pruneri, Filippo de Braud, Claudio Vernieri	4
4	Factors associated with enrolment in clinical trials among women with early-stage breast cancer 2022 ·ESMO Open ·Daniele Presti, Julie Havas, Davide Soldato, (unknown), Élise Martin, Barbara Pistilli, Christelle Jouannaud, George Emile, Olivier Rigal, Marion Fournier, P Soulié, M-A Mouret-Reynier, Carole Tarpin, Mario Campone, (unknown), (unknown), Sibille Everhard, Antonio Di Meglio	2
5	Tumor infiltrating lymphocytes (TILs) as a predictive biomarker of response to checkpoint blockers in solid tumors: A systematic review 2022 ·Critical Reviews in Oncology/Hematology ·Daniele Presti, Filippo Gustavo Dall’Olio, Benjamin Besse, Joana Ribeiro, Antonio Di Meglio, Davide Soldato	46
6	Abstract P3-12-12: ATTITUDE: Understanding and reducing ATTrition in longiTUDinal studiEs of cancer survivors 2022 ·Cancer Research ·(unknown), Julie Havas, Daniele Presti, Davide Soldato, Élise Martin, Barbara Pistilli, Aurélie Bertaut, (unknown), (unknown), Anne‐Laure Martin, Sibille Everhard, Alexandra Jacquet, Gwenn Menvielle, Matteo Lambertini, Laurence Vanlemmens, Stefan Michiels, Fabrice André, Inês Vaz-Luís, Antonio Di Meglio	1
7	Abstract P4-11-34: An integrated clinical, behavioral and biological model to predict the risk of weight gain among breast cancer survivors (BCS) 2022 ·Cancer Research ·Davide Soldato, Antonio Di Meglio, Caroline Pradon, (unknown), Daniele Presti, Julie Havas, (unknown), Barbara Pistilli, Valérie Camara‐Clayette, Fabrice André, (unknown), Sibille Everhard, Sandrine Boyault, Paul-Henry Cournède, Stefan Michiels, Inês Vaz-Luís, Stergios Christodoulidis	2
8	Lifestyle and quality of life in patients with early-stage breast cancer receiving adjuvant endocrine therapy 2021 ·Current Opinion in Oncology ·Antonio Di Meglio, Davide Soldato, Daniele Presti, Inês Vaz-Luís	9
9	Patterns of treatment and outcome of palbociclib plus endocrine therapy in hormone receptor-positive/HER2 receptor-negative metastatic breast cancer: a real-world multicentre Italian study 2021 ·Therapeutic Advances in Medical Oncology ·Raffaella Palumbo, Rosalba Torrisi, Federico Sottotetti, Daniele Presti, Anna Gambaro, Elena Collovà, (unknown), Elisa Agostinetto, Cristina Teragni, (unknown), Barbara Tagliaferri, (unknown), Antônio Bernardo, Erica Quaquarini	17
10	1694P Coffee and tea consumption (CTC), patient-reported (PRO), and clinical outcomes in a longitudinal study of patients (pts) with breast cancer (BC) 2021 ·Annals of Oncology ·Davide Soldato, Julie Havas, Daniele Presti, (unknown), (unknown), Barbara Pistilli, Élise Martin, Lucia Del Mastro, (unknown), (unknown), Charles Coutant, Paul Cottu, (unknown), F. Lerebours, Olivier Trédan, Laurence Vanlemmens, Fabrice André, Inês Vaz-Luís, Antonio Di Meglio	1
11	Gastric Adenocarcinoma at the Joliot Curie Institute in Dakar: Epidemiological, Diagnostic and Therapeutic Aspects about 54 Cases 2021 ·Journal of Cancer Therapy ·(unknown), (unknown), (unknown), (unknown), Daniele Presti, (unknown), (unknown), Ahmadou Dem	0
12	Impact of COVID-19 Outbreak on Cancer Patient Care and Treatment: Data from an Outpatient Oncology Clinic in Lombardy (Italy) 2020 ·Cancers ·Erica Quaquarini, (unknown), Daniele Presti, (unknown), Valentina Tibollo, Alberto Malovini, Raffaella Palumbo, Cristina Teragni, (unknown), Luca Mollica, Elisa Biscaldi, Mara Frascaroli, Antônio Bernardo, Federico Sottotetti	27
13	Role of androgen receptor expression in early stage ER+/PgR−/HER2– breast cancer 2020 ·Therapeutic Advances in Medical Oncology ·Barbara Tagliaferri, Erica Quaquarini, Raffaella Palumbo, (unknown), Daniele Presti, Alberto Malovini, Manuela Agozzino, Cristina Teragni, (unknown), Antônio Bernardo, Laura Villani, Federico Sottotetti	11
14	Bilateral Breast Metastases from Epstein-Barr Virus-Associated Gastric Cancer during Pregnancy: Is There a Method to Its Madness? 2019 ·Journal of the Korean Gastric Cancer Association ·Erica Quaquarini, Alessandro Vanoli, Mara Frascaroli, Alessandra Viglio, Marco Lucioni, Daniele Presti, (unknown), Andrea Pietrabissa, Antônio Bernardo, Marco Paulli	1
15	Bilateral Breast Metastases from Epstein-Barr Virus-Associated Gastric Cancer during Pregnancy: Is There a Method to Its Madness? 2019 ·Journal of the Korean Gastric Cancer Association ·Erica Quaquarini, Alessandro Vanoli, Mara Frascaroli, Alessandra Viglio, Marco Lucioni, Daniele Presti, (unknown), Andrea Pietrabissa, Antônio Bernardo, Marco Paulli	1
16	The PI3K/AKT/mTOR and CDK4/6 Pathways in Endocrine Resistant HR+/HER2− Metastatic Breast Cancer: Biological Mechanisms and New Treatments 2019 ·Cancers ·Daniele Presti, Erica Quaquarini	79
17	Effectiveness of trastuzumab emtansine (TDM1) in patients with HER2-positive advanced breast cancer (ABC) progressing after taxane plus pertuzumab plus trastuzumab 2018 ·Annals of Oncology ·Benedetta Conte, Alessandra Fabi, Francesca Poggio, Eva Blondeaux, Chiara Dellepiane, (unknown), Annamaria Staiano, Giuseppe Buono, Grazia Arpino, Valentina Magri, Giuseppe Naso, Daniele Presti, Silvia Mura, Andrea Fontana, Francesco Cognetti, Chiara Molinelli, (unknown), Claudia Bighin, Matteo Lambertini, Lucia Del Mastro	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact